iShares Biotechnology ETF (IBB)
NASDAQ: IBB · Real-Time Price · USD
167.50
+3.23 (1.97%)
At close: Jun 3, 2026, 4:00 PM EDT
167.99
+0.49 (0.29%)
After-hours: Jun 3, 2026, 6:35 PM EDT
IBB Holdings Information
IBB is an equity ETF with a total of 255 individual holdings. The top holdings are Gilead Sciences stock at 7.39%, Vertex Pharmaceuticals at 7.38%, Amgen at 7.30%, Regeneron Pharmaceuticals at 5.86%, and Alnylam Pharmaceuticals at 3.59%.
Total Holdings
255
Top 10 Percentage
45.15%
Asset Class
Equity
ETF Category
Health
Assets
7.53B
PE Ratio
21.07
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences, Inc. | 7.39% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 7.38% |
| 3 | AMGN | Amgen Inc. | 7.30% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.86% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.59% |
| 6 | ARGX | argenx SE | 3.51% |
| 7 | NTRA | Natera, Inc. | 2.67% |
| 8 | BIIB | Biogen Inc. | 2.64% |
| 9 | RVMD | Revolution Medicines, Inc. | 2.49% |
| 10 | ILMN | Illumina, Inc. | 2.31% |
| 11 | UTHR | United Therapeutics Corporation | 2.18% |
| 12 | INSM | Insmed Incorporated | 2.11% |
| 13 | ONC | BeOne Medicines AG | 1.86% |
| 14 | INCY | Incyte Corporation | 1.74% |
| 15 | MRNA | Moderna, Inc. | 1.58% |
| 16 | NBIX | Neurocrine Biosciences, Inc. | 1.44% |
| 17 | ROIV | Roivant Sciences Ltd. | 1.32% |
| 18 | EXEL | Exelixis, Inc. | 1.16% |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 1.13% |
| 20 | GMAB | Genmab A/S | 1.09% |
| 21 | BBIO | BridgeBio Pharma, Inc. | 1.01% |
| 22 | MEDP | Medpace Holdings, Inc. | 0.97% |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 0.97% |
| 24 | ASND | Ascendis Pharma A/S | 0.95% |
| 25 | AXSM | Axsome Therapeutics, Inc. | 0.91% |
As of Jun 2, 2026